Novo Nordisk CEO: Compared to injections, we are increasingly surprised that the oral version of Wegovy is in high demand in the market.

Zhitongcaijing · 2d ago
Novo Nordisk CEO: Compared to injections, we are increasingly surprised that the oral version of Wegovy is in high demand in the market.